FDA issues update on COVID-19 treatments, hemodialysis machine risk

May 09, 2022 - 03:45 PM
FDA Update 900x400

The Food and Drug Administration last week extended to 24 months the shelf life for certain lots of refrigerated bamlanivimab. The combination monoclonal antibody therapy bamlanivimab and etesevimab is currently not authorized to treat or prevent COVID-19 in any U.S. region because it is not effective against the omicron variant. However, the Department of Health and Human Services and FDA recommend retaining both products in case future COVID-19 variants are susceptible to them, and are evaluating whether to extend the shelf life for etesevimab in the future.

In other news, FDA last week released a screening checklist and drug interaction tool to help prescribers identify patients eligible for the Pfizer COVID-19 antiviral pill Paxlovid; and a dashboard summarizing data from its project to track SARS-CoV-2 variants from wastewater samples. 

The agency also alerted health care providers that certain hemodialysis machines made by Fresenius Medical Care may expose patients to toxic chemicals, and recommended certain actions to ensure patients continue to receive needed care.

Related News Articles

Headline
AHA podcast: To Mitigate and Prevent — CommonSpirit Health's Transparent Culture and Error Reporting Toolkit
In this “Safety Speaks” conversation, CommonSpirit Health's Beth Miller, system director, patient safety-performance improvement, and Austin Peterson, system…
Headline
View the AHA's latest United Against the Flu toolkit celebrating fall
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the…
Headline
CDC recommends two doses of COVID-19 vaccine for older individuals, lowers pneumococcal vaccine age 
The Centers for Disease Control and Prevention last week endorsed a recommendation for people aged 65 and older and for immunocompromised individuals to…
Headline
CDC reminds hospital and health system workers to protect themselves, patients during respiratory virus season
The Centers for Disease Control and Prevention is reminding clinicians and other health care workers to take necessary steps to keep themselves and their…
Chairperson's File
Chair File: The Best Defense Against Flu and COVID-19
Autumn is here, and that means cooler weather and also the start of flu season.We know the best way to prevent influenza is to get a flu vaccine. The Centers…
Headline
Survey: Less than 20% of U.S. adults concerned for themselves or family receiving infection ahead of respiratory virus season
The National Foundation for Infectious Diseases Sept. 25 released a survey showing that less than one in five U.S. adults are concerned about themselves or a…